Altering metabolism to treat pancreatic cancer with Marcus S Noel

In this video interview we speak with Marcus S Noel from the University of Rochester Medical Center (NY, USA) about how altering the metabolism of tumors could be used as a treatment option for pancreatic cancer, including details of the TRYbeCA1 study. The TRYbeCA1 trial is investigating eryaspase in combination with chemotherapy versus chemotherapy alone as a second line treatment for pancreatic ductal adenocarcinoma.

This content is supported by Erytech Pharma.